-+ 0.00%
-+ 0.00%
-+ 0.00%

SELLAS LIFE SCIENCES GROUP - TO REPORT TOPLINE PRIMARY ENDPOINT RESULTS FROM REGAL TRIAL THIS QUARTER

Reuters·10/28/2026 12:35:00

Please log in to view news